Previous 10 | Next 10 |
Intuitive, optical-based technology system now available around the world LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for B-Capta ® , the...
300th patient randomized in ANTHEM-HFrEF pivotal study LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced it has randomized the 300th patient in the A uto n omic Regulation Th erapy to E nhance M yocard...
Harris Associates’ 13F portfolio value increased from $41.07B to $51.71B this quarter. They added CNH Industrial and doubled Keurig Dr Pepper while dropping CVS Health and Baidu. The top three positions are Alphabet, CNH Industrial, and Bank of America, and they add up to ~...
LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first quarter 2021 results on Wednesday, April 28, 2021 at 12 p.m. London time (7 a.m. Eastern Daylight Time). The Company will release its first quarter 20...
NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Sherrie Perkins, effective March 15, 2...
A LivaNova (LIVN) buyout at $90/share may be an attractive outcome, Piper Sandler writes after FT report yesterday that PE firm Permira bid more than $80/share last month for the company.Initially, Piper Sandler analyst Adam Maeder wrote that any takeout offer below $90 would likely not resul...
LivoNova (LIVN) rose after an FT report of Permira bid for $3.75b.The offer made in February values the company at more than $80 a share, the FT report said.Developing story ... For further details see: LivoNova gains after report of Permira $3.75b bid
The following slide deck was published by LivaNova PLC in conjunction with their 2020 Q4 earnings call. For further details see: LivaNova PLC 2020 Q4 - Results - Earnings Call Presentation
LivaNova PLC (LIVN) Q4 2020 Earnings Conference Call February 24, 2021 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President of Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Interim Chief Financial Officer Melissa Farina - Vice President o...
Image source: The Motley Fool. LivaNova PLC (NASDAQ: LIVN) Q4 2020 Earnings Call Feb 24, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: LivaNova PLC (LIVN) Q4 2020 Earnings Call Transcript
News, Short Squeeze, Breakout and More Instantly...
2024-06-23 00:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time). The Company will release its second-quarter 2024 results prior to the call. ...
2024-06-06 11:00:14 ET Rick Wise from Stifel Nicolaus issued a price target of $70.00 for LIVN on 2024-06-06 09:52:00. The adjusted price target was set to $70.00. At the time of the announcement, LIVN was trading at $53.16. The overall price target consensus is at $69.5...